These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20570841)

  • 1. Compatibility of drug infusions in the NICU.
    Kalikstad B; Skjerdal A; Hansen TW
    Arch Dis Child; 2010 Sep; 95(9):745-8. PubMed ID: 20570841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preparation of a compatibility chart for intravenous drug therapy in neonatal and pediatric intensive care units].
    Höpner JH; Schulte A; Thiessen J; Knuf M; Huth RG
    Klin Padiatr; 2007; 219(1):37-43. PubMed ID: 17205430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication use in the neonatal intensive care unit: current patterns and off-label use of parenteral medications.
    Kumar P; Walker JK; Hurt KM; Bennett KM; Grosshans N; Fotis MA
    J Pediatr; 2008 Mar; 152(3):412-5. PubMed ID: 18280851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial of 72- versus 24-hour intravenous tubing set changes in newborns receiving lipid therapy.
    Matlow AG; Kitai I; Kirpalani H; Chapman NH; Corey M; Perlman M; Pencharz P; Jewell S; Phillips-Gordon C; Summerbell R; Ford-Jones EL
    Infect Control Hosp Epidemiol; 1999 Jul; 20(7):487-93. PubMed ID: 10432161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unlicensed and off-label drug use in an Irish neonatal intensive care unit: a prospective cohort study.
    Kieran EA; O'Callaghan N; O'Donnell CP
    Acta Paediatr; 2014 Apr; 103(4):e139-42. PubMed ID: 24397831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unlicensed and off-label medication use in a neonatal intensive care unit: a prospective study.
    Barr J; Brenner-Zada G; Heiman E; Pareth G; Bulkowstein M; Greenberg R; Berkovitch M
    Am J Perinatol; 2002 Feb; 19(2):67-72. PubMed ID: 11938479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A summary of NICU fat emulsion medication errors and nursing services: data from MEDMARX.
    Hicks RW; Becker SC; Chuo J
    Adv Neonatal Care; 2007 Dec; 7(6):299-308; quiz 309-10. PubMed ID: 18097212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compatibility considerations in parenteral nutrient solutions.
    Niemiec PW; Vanderveen TW
    Am J Hosp Pharm; 1984 May; 41(5):893-911. PubMed ID: 6328980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parenteral nutrition objectives for very low birth weight infants: results of a national survey.
    Lapillonne A; Fellous L; Mokthari M; Kermorvant-Duchemin E
    J Pediatr Gastroenterol Nutr; 2009 May; 48(5):618-26. PubMed ID: 19367179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of methods for intravenous infusion of fat emulsion during extracorporeal membrane oxygenation.
    Buck ML; Wooldridge P; Ksenich RA
    Pharmacotherapy; 2005 Nov; 25(11):1536-40. PubMed ID: 16232016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Connecting multiple low-flow intravenous infusions in the newborn: problems and possible solutions.
    Levi DS; Peterson N; Shah SD; Rakholia B; Haught A; Carman G
    Pediatr Crit Care Med; 2010 Mar; 11(2):275-81. PubMed ID: 20068501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supporting the use of sildenafil infusions in paediatric and neonatal intensive care - A compatibility study.
    AlSalman F; Howlett M; Breatnach C; Kelly H; O'Brien F
    Eur J Pharm Biopharm; 2020 Jun; 151():153-161. PubMed ID: 32289494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of di(2-ethylhexyl)phthalate-containing infusion systems increases the risk for cholestasis.
    von Rettberg H; Hannman T; Subotic U; Brade J; Schaible T; Waag KL; Loff S
    Pediatrics; 2009 Aug; 124(2):710-6. PubMed ID: 19651587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance and assessment of the compatibility of mixed solutions with fat emulsion components for parenteral nutrition].
    Semler P; Sommermeyer K
    Infusionsther Klin Ernahr; 1987 Dec; 14(6):274-82. PubMed ID: 3126138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-administration of drugs with parenteral nutrition in the neonatal intensive care unit-physical compatibility between three components.
    Nilsson N; Storesund I; Tho I; Nezvalova-Henriksen K
    Eur J Pediatr; 2022 Jul; 181(7):2685-2693. PubMed ID: 35422115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Compatibility problems in intensive care medicine].
    Schröder F
    Infusionsther Transfusionsmed; 1994 Feb; 21(1):52-8. PubMed ID: 8173313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection.
    De Jongh R; Hens R; Basma V; Mouton JW; Tulkens PM; Carryn S
    J Antimicrob Chemother; 2008 Feb; 61(2):382-8. PubMed ID: 18070831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aluminum content in intravenous solutions for administration to neonates: role of product preparation and administration methods.
    de Oliveira SR; Bohrer D; Garcia SC; do Nascimento PC; Noremberg S
    JPEN J Parenter Enteral Nutr; 2010; 34(3):322-8. PubMed ID: 20467015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug stability and compatibility in oncology care.
    Williams DA
    J Infus Chemother; 1996; 6(4):195-202. PubMed ID: 9229315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of amino acid infusions on fructose-induced chemical blood changes in intensive care patients].
    Förster H; Dudziak R; Steuer A; Boecker S
    Infusionsther Klin Ernahr; 1976 Aug; 3(4):228-35. PubMed ID: 821861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.